The diffuse growth pattern, CD23 expression, and similar light chain expression of the two lymphomas threw up many diagnostic challenges, which required careful morphologic assessment as well as ancillary testing with flow cytometry and genetic studies for accurate diagnosis. The gene discussed is FCER2; the disease is lymphoma.